Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2025-12-31 @ 9:19 PM
Study NCT ID:
NCT01942135
Status:
COMPLETED
Last Update Posted:
2024-04-04
First Post:
2013-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-26
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-28
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-10
First Submit QC Date:
None
Study First Post Date:
2013-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-03
Results First Submit QC Date:
None
Results First Post Date:
2016-05-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-01
Last Update Post Date:
2024-04-04
Last Update Post Date Type:
ACTUAL